Hematology

The National Academy of Medicine elects Alexis Thompson, MD, MPH, for her significant contributions to sickle cell disease research.

CHOP researchers developed a factor VIII variant that led to safe and long-lasting therapeutic results in preclinical models.

Subecha “Suvy” Dahal shares how she discovered a natural inclination for creating whimsical oil paintings.

Decades ago, Katherine A. High, MD, and colleagues began an unprecedented journey to develop a new kind of treatment for hemophilia B.

This week, AACR names CHOP physician-scientists as grant recipients, and CIRP researchers publish new findings on driving and mood disorders.

CHOP's NoT Bleeding Program will conduct clinical trials to develop the next generation of therapeutics for hemophilia A, B, and other bleeding disorders.

In this Q&A, hematologist Dr. Kwiatkowski discusses the Food and Drug Administration approval of beti-cel (Zynteglo®), a gene therapy for beta thalassemia.

Congratulations to Garrett Brodeur, MD, recipient of the American Society of Pediatric Hematology/Oncology Distinguished Career Award.

CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.

Researchers work to enhance the body’s immune response to contain infection locally and prevent systemic bacterial spread.